Serum uric acid level predicts the progression of amyotrophic lateral sclerosis following treatment with edaravone.

Published in: Redox report : communications in free radical research (2022)

High baseline values and low rate of decline in uric acid may predict slow disease progression in ALS patients treated with edaravone.

Keyphrases